PRESS RELEASE
Published March 11, 2026
Cork, Ireland – Applied Biopharm Consulting Ltd has been awarded an Intellectual Property (IP) Start Grant from the Local Enterprise Office beneath Enterprise Ireland’s IP Strategy initiative.
The grant will help the corporate in securing specialist mental property advisory providers to guard improvements rising from its synthetic intelligence-driven viral capsid engineering analysis program.
The IP Start Grant allows firms to interact exterior mental property specialists to conduct prior-art analysis and develop a proper patent technique. Applied Biopharm Consulting will use this help to judge and shield biomolecular improvements arising from its proprietary computational platform for engineered viral vector design.
Building on a 2024 feasibility examine supported by the Local Enterprise Office Cork North & West, the corporate has continued creating superior strategies that combine synthetic intelligence, structural bioinformatics and molecular simulation strategies to enhance the efficiency of engineered adeno-associated virus (AAV) vectors.
The platform is designed to boost vector focusing on and binding interactions with potential functions throughout a spread of superior therapeutic modalities, together with next-generation gene therapies and precision biologics improvement.
Initial analysis outcomes point out robust potential for protectable improvements throughout key facets of viral vector engineering and computational biomolecular design, supporting the corporate’s long-term technique to develop proprietary applied sciences alongside its established consulting providers.
Dr. Anthony Newcombe, Managing Director of Applied Biopharm Consulting Ltd, stated:
“Securing the IP Start Grant represents an important milestone as we transition our capsid engineering research from early feasibility toward protected innovation. As we continue advancing AI-driven molecular design capabilities for viral vector development, establishing a strong intellectual property foundation is essential to maximising long-term value and enabling future partnerships.”
A spokesperson for the Local Enterprise Office Cork North & West added:
“We are pleased to support Applied Biopharm Consulting through the IP Start Grant under Enterprise Ireland’s IP Strategy initiative. Protecting intellectual property is a crucial step for innovative companies as they scale and commercialise their technologies, and we look forward to seeing the continued progression of this advanced research programme.”
The grant underscores Applied Biopharm Consulting’s strategic growth past consulting providers into proprietary biotechnology innovation, whereas sustaining its core concentrate on supporting international biopharmaceutical firms in GMP compliance, Regulatory CMC, Manufacturing Science and Technology (MSAT), Quality Assurance and expertise switch actions.
By combining intensive regulatory and manufacturing experience with next-generation biologics engineering capabilities, the corporate is positioning itself on the intersection of superior remedy improvement, viral vector and AI-driven biomolecular engineering.
About Applied Biopharm Consulting Ltd
Applied Biopharm Consulting Ltd is a specialist bioprocess and GMP consulting agency supporting biopharmaceutical and superior remedy firms worldwide. The firm supplies experience in Regulatory CMC, GMP auditing and compliance, Manufacturing Science and Technology (MSAT), expertise switch, GMP manufacturing and Quality Assurance.
In parallel with its consulting actions, Applied Biopharm Consulting is advancing an inner analysis and improvement programme targeted on next-generation viral vector engineering and AI-driven molecular design. This initiative leverages the corporate’s regulatory, manufacturing and course of improvement experience to help the event of modern applied sciences for the event of next-generation viral vector applied sciences.
For extra info, please contact:
Anthony Newcombe, Managing Director
Applied Biopharm Consulting Ltd
Mob: +353 (0) 873634486
Sharleen Foody, Senior Enterprise Development Officer
Mob: +353 (22) 43235
Disclaimer: Information contained on this web page is offered by an impartial third-party content material supplier. Digitaljournal.com doesn’t take accountability of the content material printed right here.